세계의 의약품 제조 시장 보고서(2025년)

Pharmaceutical Manufacturing Global Market Report 2025

US $ 4,490 ￦ 6,290,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,091,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,893,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

의약품 제조 시장 규모는 향후 몇 년 동안 급속한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 개인 맞춤형 의학의 부상, 고령 인구 증가, 바이오시밀러에 대한 수요 증가, 지역 제조에 대한 정부 지원, 만성 질환의 유병률 증가에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 연속 제조의 발전, 인공 지능의 통합, 스마트 제조 기술의 채택, 생물학적 제제 생산의 혁신, 연구 개발 효율성 개선에 대한 집중 등이 있습니다.

만성 질환의 유병률이 증가함에 따라 향후 몇 년 동안 의약품 제조 시장의 확장이 촉진될 것으로 예상됩니다. 만성 질환은 일반적으로 서서히 진행되고 1년 이상 지속되며, 지속적인 치료가 필요하거나 일상 생활에 영향을 미치는 장기적인 건강 상태입니다. 만성 질환의 증가는 주로 기대 수명의 증가, 앉아있는 생활 방식, 잘못된 식습관으로 인해 발생하며, 이러한 요인들은 모두 장기적인 의료 솔루션 및 예방적 건강 관리 조치에 대한 필요성을 높입니다. 의약품 제조는 필수 의약품의 안정적 공급을 보장하고, 의약품 개발의 혁신을 촉진하며, 효과적인 장기 치료에 대한 증가하는 수요를 충족함으로써 만성 질환에 대처하는 데 중요한 역할을 합니다. 예를 들어, 2024년 9월, 영국 정부 기관인 국민건강서비스(NHS)는 35세 이상 성인의 11%가 진행성 만성 신장 질환을 앓고 있으며, 그 유병률과 중증도는 연령이 증가함에 따라 높아진다고 보고했습니다. 75세 이상 인구의 약 48%가 어떤 형태의 만성 질환을 앓고 있으며, 36%는 더 심각한 단계에 있습니다. 따라서 만성 질환의 유병률이 증가하면서 의약품 제조 시장의 성장이 촉진되고 있습니다.

의약품 제조 시장의 기업들은 생산 효율성을 높이고, 높은 품질 기준을 보장하며, 표적 암 치료에 대한 증가하는 수요를 충족하기 위해 완전 자동화된 RLT 제조 시설과 같은 첨단 솔루션을 개발하는 데 집중하고 있습니다. 자동화된 RLT 제조 시설은 첨단 자동화 기술을 활용하여 방사성 리간드 치료제의 생산을 최적화하고 간소화하여 일관되고 효율적이며 확장 가능한 제조를 보장합니다. 예를 들어, 2024년 1월, 스위스에 본사를 둔 제약 회사인 Novartis AG는 인디애나폴리스에 있는 최신 방사성 리간드 치료제(RLT) 제조 시설에서 Pluvicto를 생산하는 것을 미국 식품의약국(FDA)으로부터 승인받았습니다. 이 확장은 Pluvicto 및 Lutathera를 포함한 방사성 리간드 치료제 의약품의 생산 능력을 크게 향상시킬 것입니다. 이 움직임은 전 세계적으로 증가하는 표적 암 치료에 대한 수요를 충족하고 세계의 환자의 접근성을 개선하기 위한 Novartis의 더 큰 전략의 일부입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 의약품 제조 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 의약품 제조 시장 : 성장률 분석
• 세계의 의약품 제조 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 의약품 제조 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 의약품 제조 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 의약품 제조 시장 : 분자 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 생물학적제제 및 바이오시밀러
• 기존 의약품
• 세계의 의약품 제조 시장 : 제형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 정제
• 캡슐
• 주사제
• 스프레이
• 현탁액
• 분말
• 기타 제형
• 세계의 의약품 제조 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구
• 외용
• 비경구
• 흡입
• 기타 투여 경로
• 세계의 의약품 제조 시장 : 치료 영역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 심혈관 질환(CVD)
• 통증
• 당뇨병
• 암
• 호흡기 질환
• 기타 병
• 세계의 의약품 제조 시장 : 판매 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 소매
• 비소매
• 세계의 의약품 제조 시장, 생물학적 제제 및 바이오시밀러 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 단일클론항체
• 백신
• 재조합 단백질
• 세포 요법
• 유전자 치료
• 호르몬
• 혈액 및 혈장 제품
• 세계의 의약품 제조 시장, 기존 의약품 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 진통제
• 해열제
• 항생제
• 항바이러스제
• 항진균제
• 강압제
• 항우울제
• 항당뇨병제

제7장 지역별, 국가별 분석

• 세계의 의약품 제조 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 의약품 제조 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 의약품 제조 시장 : 경쟁 구도
• 의약품 제조 시장 : 기업 프로파일
  • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Sanofi SA
• Bristol Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceuticals Inc.
• Eli Lilly and Company
• Gilead Sciences Inc.
• Novo Nordisk A/S
• Lonza Group AG
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories
• Cipla Limited

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 의약품 제조 시장(2029년) : 새로운 기회를 제공하는 국가
• 의약품 제조 시장(2029년) : 새로운 기회를 제공하는 부문
• 의약품 제조 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

HBR

영문 목차

영문목차

Pharmaceutical manufacturing is the industrial process of creating, producing, and packaging medications and medical products at scale, utilizing chemical synthesis, biological processing, and the formulation of active and inactive ingredients. This process is conducted under strict regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for both human and veterinary use within global healthcare systems.

The primary molecule types in pharmaceutical manufacturing include biologics, biosimilars, and conventional drugs. Tablets are solid, flat medications containing a specific amount of active ingredients. Other formulations include capsules, injectables, sprays, suspensions, powders, and more, which are administered via various routes such as oral, topical, parenteral, inhalation, and others. Pharmaceutical manufacturing serves a wide range of therapy areas, including cardiovascular diseases (CVDs), pain management, diabetes, cancer, respiratory diseases, and more. These products are distributed through both retail and non-retail sales channels.

The pharmaceutical manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical manufacturing market statistics, including the pharmaceutical manufacturing industry's global market size, regional shares, competitors with an pharmaceutical manufacturing market share, detailed pharmaceutical manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical manufacturing industry. This pharmaceutical manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical manufacturing market size has grown rapidly in recent years. It will grow from $519.78 billion in 2024 to $573.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to the increasing global disease burden, rising healthcare spending, growing demand for generic drugs, patent expirations of blockbuster drugs, and the expansion of pharmaceutical production capacity.

The pharmaceutical manufacturing market size is expected to see rapid growth in the next few years. It will grow to $846.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the rise of personalized medicine, the expanding elderly population, increasing demand for biosimilars, government support for local manufacturing, and the growing prevalence of chronic diseases. Key trends in the forecast period include advancements in continuous manufacturing, the integration of artificial intelligence, the adoption of smart manufacturing technologies, innovations in biologics production, and a focus on improving research and development efficiency.

The growing prevalence of chronic diseases is expected to drive the expansion of the pharmaceutical manufacturing market in the coming years. Chronic diseases are long-term health conditions that typically develop gradually and persist for a year or more, often requiring ongoing medical care or impacting daily activities. The rise in chronic diseases is largely due to increasing life expectancy, sedentary lifestyles, and poor dietary habits, all contributing to a greater need for long-term healthcare solutions and preventive wellness measures. Pharmaceutical manufacturing plays a crucial role in addressing chronic diseases by ensuring a steady supply of essential medications, fostering innovation in drug development, and meeting the rising demand for effective long-term treatments. For example, in September 2024, the National Health Service (NHS), a UK government organization, reported that 11% of adults aged 35 and older have advanced chronic kidney disease, with the prevalence and severity increasing with age. Nearly 48% of individuals aged 75 and above suffer from some form of the disease, and 36% have more severe stages. Thus, the growing prevalence of chronic diseases is driving growth in the pharmaceutical manufacturing market.

Major companies in the pharmaceutical manufacturing market are concentrating on developing advanced solutions, such as fully automated RLT manufacturing facilities, to boost production efficiency, ensure high-quality standards, and address the rising demand for targeted cancer therapies. An automated RLT manufacturing facility utilizes advanced automation technologies to optimize and streamline the production of radioligand therapies, ensuring consistent, efficient, and scalable manufacturing. For example, in January 2024, Novartis AG, a Switzerland-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) to produce Pluvicto at a cutting-edge radioligand therapy (RLT) manufacturing facility in Indianapolis. This expansion will significantly enhance the production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This move is part of Novartis' larger strategy to meet the growing global demand for targeted cancer therapies and improve patient access worldwide.

In December 2024, Novo Holdings A/S, a Denmark-based asset management company, acquired Catalent for $16.5 billion. This acquisition allows Novo Holdings to strengthen its position in the life sciences sector by leveraging Catalent's leading expertise in drug development, manufacturing, and clinical supply management. The move aims to accelerate growth, improve patient outcomes, and create sustainable value within the pharmaceutical and biotechnology industries. Catalent Inc. is a US-based pharmaceutical company that offers pharmaceutical manufacturing services.

Major players in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, and Jubilant Pharmova Limited.

North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical manufacturing market consists of revenues earned by entities by providing services such as contract manufacturing, formulation development, quality control and testing, and packaging and labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical manufacturing market also includes sales of syrups, patch formulations, biologics, and antibiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Molecule Type: Biologics And Biosimilars; Conventional Drugs
• 2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
• 3) By Route Of Administration: Oral; Topical; Parenteral; Inhalations; Other Route Of Administrations
• 4) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
• 5) By Sales Channel: Retail; Non-retail
• Subsegments:
• 1) By Biologics And Biosimilars: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell Therapies; Gene Therapies; Hormones; Blood And Plasma Products
• 2) By Conventional Drugs: Analgesics; Antipyretics; Antibiotics; Antivirals; Antifungals; Antihypertensives; Antidepressants; Antidiabetics
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Manufacturing Market Characteristics

3. Pharmaceutical Manufacturing Market Trends And Strategies

4. Pharmaceutical Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Manufacturing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Manufacturing Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Manufacturing Total Addressable Market (TAM)

6. Pharmaceutical Manufacturing Market Segmentation

• 6.1. Global Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics And Biosimilars
• Conventional Drugs
• 6.2. Global Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations
• 6.3. Global Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Parenteral
• Inhalations
• Other Route Of Administrations
• 6.4. Global Pharmaceutical Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases (CVDs)
• Pain
• Diabetes
• Cancer
• Respiratory Diseases
• Other Diseases
• 6.5. Global Pharmaceutical Manufacturing Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail
• Non-retail
• 6.6. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Cell Therapies
• Gene Therapies
• Hormones
• Blood And Plasma Products
• 6.7. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Antipyretics
• Antibiotics
• Antivirals
• Antifungals
• Antihypertensives
• Antidepressants
• Antidiabetics

7. Pharmaceutical Manufacturing Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Manufacturing Market

• 8.1. Asia-Pacific Pharmaceutical Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Manufacturing Market

• 9.1. China Pharmaceutical Manufacturing Market Overview
• 9.2. China Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Manufacturing Market

• 10.1. India Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Manufacturing Market

• 11.1. Japan Pharmaceutical Manufacturing Market Overview
• 11.2. Japan Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Manufacturing Market

• 12.1. Australia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Manufacturing Market

• 13.1. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Manufacturing Market

• 14.1. South Korea Pharmaceutical Manufacturing Market Overview
• 14.2. South Korea Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Manufacturing Market

• 15.1. Western Europe Pharmaceutical Manufacturing Market Overview
• 15.2. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Manufacturing Market

• 16.1. UK Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Manufacturing Market

• 17.1. Germany Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Manufacturing Market

• 18.1. France Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Manufacturing Market

• 19.1. Italy Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Manufacturing Market

• 20.1. Spain Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Manufacturing Market

• 21.1. Eastern Europe Pharmaceutical Manufacturing Market Overview
• 21.2. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Manufacturing Market

• 22.1. Russia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Manufacturing Market

• 23.1. North America Pharmaceutical Manufacturing Market Overview
• 23.2. North America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Manufacturing Market

• 24.1. USA Pharmaceutical Manufacturing Market Overview
• 24.2. USA Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Manufacturing Market

• 25.1. Canada Pharmaceutical Manufacturing Market Overview
• 25.2. Canada Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Manufacturing Market

• 26.1. South America Pharmaceutical Manufacturing Market Overview
• 26.2. South America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Manufacturing Market

• 27.1. Brazil Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Manufacturing Market

• 28.1. Middle East Pharmaceutical Manufacturing Market Overview
• 28.2. Middle East Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Manufacturing Market

• 29.1. Africa Pharmaceutical Manufacturing Market Overview
• 29.2. Africa Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Manufacturing Market Competitive Landscape
• 30.2. Pharmaceutical Manufacturing Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Manufacturing Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. GlaxoSmithKline plc
• 31.8. Takeda Pharmaceuticals Inc.
• 31.9. Eli Lilly and Company
• 31.10. Gilead Sciences Inc.
• 31.11. Novo Nordisk A/S
• 31.12. Lonza Group AG
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Dr. Reddy's Laboratories
• 31.15. Cipla Limited

32. Global Pharmaceutical Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Manufacturing Market

34. Recent Developments In The Pharmaceutical Manufacturing Market

35. Pharmaceutical Manufacturing Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Manufacturing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Manufacturing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Manufacturing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료